title: [Neuroendocrine dysfunctions during psychopharmacological treatment: clinical presentations, diagnosis, risk factors and treatment].
abstract: We present a review of the literature on clinical presentations, diagnosis, treatment and prevention of neuroendocrine dysfunctions (NED) in patients with mental disorders during psychopharmacological treatment. Prolactinemia syndrome, metabolic syndrome and dysthyreosis are considered. Risk factors for NED and practical recommendations on diagnostic and therapeutic approaches to NED minimization are presented.
authors: L N
authors: LN
authors: Gorobets
authors: G E
authors: GE
authors: Mazo
mesh_terms: D014150:Antipsychotic Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D006966:Hyperprolactinemia / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy; D001523:Mental Disorders / Q000150:complications / Q000188:drug therapy*; D024821:Metabolic Syndrome / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy; D009490:Neurosecretory Systems / Q000187:drug effects; D013959:Thyroid Diseases / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy
chemical_list: D014150:Antipsychotic Agents